Figure 1 | British Journal of Cancer

Figure 1

From: How to minimise the effect of tumour cell content in detection of aberrant genetic markers in neuroblastoma

Figure 1

Kaplan–Meier curves showing the effect of tumour cell content on clinical impact of aberrant (numeric or structural) genetic markers (AGM) in neuroblastoma patients. (A and B) Event-free survival (EFS) and overall survival (OS) of patients with tumours without AGM according to tumour cell content of sample. (C and D) EFS and OS of patients suffering with tumours with AGM according to tumour cell content of sample.

Back to article page